Kohortenstudie
Impact of atrial fibrillation on the risk for new-onset chronic kidney disease and all-cause mortality: A prospective cohort study
Clinical Nephrology · 2025
DOI: 10.5414/cn111257 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Nephrology, 2025. Verfasst von Bocheng Yue und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Atrial Fibrillation, Renal Insufficiency, Chronic.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Atrial FibrillationRenal Insufficiency, ChronicHumansMaleFemaleMiddle AgedAgedProspective StudiesIncidenceRisk FactorsProportional Hazards ModelsChinaKaplan-Meier EstimateCause of DeathPropensity ScoreTime FactorsRisk Assessment
Zitieren
APA
Yue, B., Hou, Q., Li, X., Han, Q., Zhang, A., Cao, H., Wu, S., & Li, K. (2025). Impact of atrial fibrillation on the risk for new-onset chronic kidney disease and all-cause mortality: A prospective cohort study. Clinical Nephrology. https://doi.org/10.5414/cn111257
Vancouver
Yue B, Hou Q, Li X, Han Q, Zhang A, Cao H, et al. Impact of atrial fibrillation on the risk for new-onset chronic kidney disease and all-cause mortality: A prospective cohort study. Clinical Nephrology. 2025. doi:10.5414/cn111257
BibTeX
@article{Yue2025,
author = {Yue, Bocheng and Hou, Qiqi and Li, Xinyi and Han, Quanle and Zhang, Aili and Cao, Hongxia and Wu, Shouling and Li, Kangbo},
title = {Impact of atrial fibrillation on the risk for new-onset chronic kidney disease and all-cause mortality: A prospective cohort study},
journal = {Clinical Nephrology},
year = {2025},
doi = {10.5414/cn111257}
}
EUVIMED